ENAapplication/xmlftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR277/081/SRR27720181/SRR27720181_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR277/080/SRR27720180/SRR27720180_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR277/079/SRR27720179/SRR27720179_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR277/078/SRR27720178/SRR27720178_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR277/081/SRR27720181/SRR27720181_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR277/080/SRR27720180/SRR27720180_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR277/079/SRR27720179/SRR27720179_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR277/078/SRR27720178/SRR27720178_2.fastq.gzprimaryOK200GenomicsKey Laboratory of Organ Regeneration & Transplantation of the Ministry of Education, The First Hospital of Jilin University, Jilin University, Changchun, Chinahttps://www.ebi.ac.uk/ena/browser/view/PRJNA1068633Mus musculusTo further understand the downstream mechanism of IL17/IL17R signaling in tumor cells, we performed transcriptome sequencing analysis of 4T1 cells treated with rIL17A Overall design: 4T1 tumor cells treated with or without recombinant IL-17A cytokines.ENAfalseIL17A-induced OPN from tumor cells promotes tumor progression by inducing tissue-resident TAM proliferation via LYVE1 [I]IL17A-induced OPN from tumor cells promotes tumor progression by inducing tissue-resident TAM proliferation via LYVE1 [I]2025-09-242024-11-17PRJNA1068633GSE25414610090